Dopamine agonist withdrawal syndrome — what do we really know?
Neurologia i Neurochirurgia Polska · 29.04.2026 · 60 (2) · 169-178
DOI: 10.5603/pjnns.110733 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurologia i Neurochirurgia Polska, online erschienen am 29.04.2026. Verfasst von Iga A Łobińska und 1 weiteren Autor:innen. Beteiligte Einrichtung: M.D. Program, Medical Faculty, Medical University of Gdansk, Poland. igalob@gumed.edu.pl. Hauptthemen laut MEDLINE: Substance Withdrawal Syndrome, Dopamine Agonists, Parkinson Disease.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- M.D. Program, Medical Faculty, Medical University of Gdansk, Poland. igalob@gumed.edu.pl.
- Department of Neurology, Neurodegenerative Disorders and Neuroimmunology, Faculty of Health Sciences, Medical University of Gdansk, Poland.
- Clinical Department of Neurology and Stroke, St. Adalbert Hospital, Copernicus Ltd., Gdansk, Poland.
ORCID-Profile: Iga A Łobińska
Zitieren
APA
Łobińska, I. A., & Sławek, J. (2026). Dopamine agonist withdrawal syndrome — what do we really know?. Neurologia i Neurochirurgia Polska, 60(2), 169-178. https://doi.org/10.5603/pjnns.110733
Vancouver
Łobińska IA, Sławek J. Dopamine agonist withdrawal syndrome — what do we really know?. Neurologia i Neurochirurgia Polska. 2026;60(2):169-178. doi:10.5603/pjnns.110733
BibTeX
@article{obiska2026,
author = {Łobińska, Iga A and Sławek, Jarosław},
title = {Dopamine agonist withdrawal syndrome — what do we really know?},
journal = {Neurologia i Neurochirurgia Polska},
year = {2026},
volume = {60},
number = {2},
pages = {169--178},
doi = {10.5603/pjnns.110733}
}
EUVIMED